Scotland chosen to lead a £26m clinical trial for arthritis sufferers
SCOTLAND, UK, December 16, 2007-A £26m study of medicines to treat the pain of arthritis, which reinforces Scotland’s place as a leader in the delivery of major clinical trials, was launched today.
The SCOT Trial, (Standard Care versus Celecoxib Outcome Trial), will compare different types of treatment for arthritis-a series of conditions which affects around nine million people in the UK.
The trial compares traditional non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac, with a newer NSAID called Celecoxib. Both types of NSAID are prescribed for the treatment of arthritis, but doctors want to know how the newer NSAID Celecoxib compares with the older NSAID in patients with arthritis in terms of long-term safety.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.